These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 14977297)

  • 21. Antiretroviral therapy: treatment-experienced individuals.
    Calvo KR; Daar ES
    Infect Dis Clin North Am; 2014 Sep; 28(3):439-56. PubMed ID: 25151565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
    ;
    Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
    [No Abstract]   [Full Text] [Related]  

  • 23. Effectiveness of first-line antiretroviral therapy and acquired drug resistance among HIV-1-infected children in India.
    Shet A; Neogi U; Sahoo PN; De Costa A
    Pediatr Infect Dis J; 2013 May; 32(5):e227-9. PubMed ID: 23249907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiretroviral Therapy.
    Brock JB; Henderson H
    J Miss State Med Assoc; 2015 Jun; 56(6):166, 171-2. PubMed ID: 26242056
    [No Abstract]   [Full Text] [Related]  

  • 25. Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings.
    Kumarasamy N; Krishnan S
    Curr Opin HIV AIDS; 2013 Nov; 8(6):586-90. PubMed ID: 24100872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Resistance of HIV-1 to antiretroviral drugs in Valencia (Spain): mutations and susceptibility].
    Molina JM; Cordoba J; Gobernado M
    Rev Esp Quimioter; 2003 Sep; 16(3):308-12. PubMed ID: 14702123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular mehanisms of drug resistance acquisition in HIV].
    Sugiura W
    Nihon Rinsho; 2009 Jan; 67(1):43-51. PubMed ID: 19177751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiretroviral drug resistance and resistance testing.
    Gallant JE
    Top HIV Med; 2005 Dec-2006 Jan; 13(5):138-42. PubMed ID: 16377851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [HIV drug resistance].
    Marcelin AG; Calvez V
    Rev Prat; 2006 May; 56(9):978-86. PubMed ID: 16775978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon.
    Meresse M; March L; Kouanfack C; Bonono RC; Boyer S; Laborde-Balen G; Aghokeng A; Suzan-Monti M; Delaporte E; Spire B; Carrieri MP; Laurent C;
    HIV Med; 2014 Sep; 15(8):478-87. PubMed ID: 24589279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiretroviral therapy: a primer for dermatologists.
    Kim HN; Harrington RD
    Dermatol Clin; 2006 Oct; 24(4):537-47, vii. PubMed ID: 17010782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries.
    De Luca A; Hamers RL; Schapiro JM
    J Infect Dis; 2013 Jun; 207 Suppl 2():S63-9. PubMed ID: 23687291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is HIV more and more resistant?].
    Chaix ML; Delaugerre C; Viard JP
    Rev Prat; 2004 Mar; 54(5):471-4. PubMed ID: 15176501
    [No Abstract]   [Full Text] [Related]  

  • 35. Transmission of HIV drug resistance and non-B subtype distribution in the Spanish cohort of antiretroviral treatment naïve HIV-infected individuals (CoRIS).
    García F; Pérez-Cachafeiro S; Guillot V; Alvarez M; Pérez-Romero P; Pérez-Elías MJ; Viciana I; Blanco JR; López-Dieguez M; de Mendoza C;
    Antiviral Res; 2011 Aug; 91(2):150-3. PubMed ID: 21663768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to antiviral drugs is climbing.
    Kmietowicz Z
    BMJ; 2005 Aug; 331(7512):308. PubMed ID: 16081434
    [No Abstract]   [Full Text] [Related]  

  • 37. Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan.
    Chang SY; Chen MY; Lee CN; Sun HY; Ko W; Chang SF; Chang KL; Hsieh SM; Sheng WH; Liu WC; Wu CH; Kao CL; Hung CC; Chang SC
    J Antimicrob Chemother; 2008 Mar; 61(3):689-93. PubMed ID: 18227088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for antiretroviral drug resistance among treatment-naive human immunodeficiency virus type 1-infected individuals in Lebanon.
    Mokhbat JM; Melhem NM; El-Khatib Z; Zalloua P
    J Infect Dev Ctries; 2014 Mar; 8(3):339-48. PubMed ID: 24619266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 drug resistance in Thailand: before and after National Access to Antiretroviral Program.
    Sutthent R; Arworn D; Kaoriangudom S; Chokphaibulkit K; Chaisilwatana P; Wirachsilp P; Thiamchai V; Sirapraphasiri T; Tanprasertsuk S
    J Clin Virol; 2005 Dec; 34(4):272-6. PubMed ID: 16286051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of antiretroviral resistance on response in treatment-experienced patients.
    Kuritzkes DR
    AIDS Read; 2003 Dec; 13(12 Suppl Antiretroviral):S5-11. PubMed ID: 19967805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.